Notify me when Sonic Fund II, L.P. files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| FENC | Fennec Pharmaceuticals Inc. | Common stock, no par value (the "Shares") | 8.2% | $21,503,685 | 2,799,959 | Kam Lawrence | 31 Dec 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|